BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34326691)

  • 1. MUC3A promotes non-small cell lung cancer progression via activating the NFκB pathway and attenuates radiosensitivity.
    Sun Y; Sun X; You C; Ma S; Luo Y; Peng S; Tang F; Tian X; Wang F; Huang Z; Yu H; Xiao Y; Wang X; Zhang J; Gong Y; Xie C
    Int J Biol Sci; 2021; 17(10):2523-2536. PubMed ID: 34326691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MUC3A induces PD-L1 and reduces tyrosine kinase inhibitors effects in EGFR-mutant non-small cell lung cancer.
    Luo Y; Ma S; Sun Y; Peng S; Zeng Z; Han L; Li S; Sun W; Xu J; Tian X; Wang F; Wu Q; Xiao Y; Zhang J; Gong Y; Xie C
    Int J Biol Sci; 2021; 17(7):1671-1681. PubMed ID: 33994852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knocking Down Nucleolin Expression Enhances the Radiosensitivity of Non-Small Cell Lung Cancer by Influencing DNA-PKcs Activity.
    Xu JY; Lu S; Xu XY; Hu SL; Li B; Qi RX; Chen L; Chang JY
    Asian Pac J Cancer Prev; 2015; 16(8):3301-6. PubMed ID: 25921135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.
    Marampon F; Gravina G; Ju X; Vetuschi A; Sferra R; Casimiro M; Pompili S; Festuccia C; Colapietro A; Gaudio E; Di Cesare E; Tombolini V; Pestell RG
    Oncotarget; 2016 Feb; 7(5):5383-400. PubMed ID: 26689991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DDB2 increases radioresistance of NSCLC cells by enhancing DNA damage responses.
    Zou N; Xie G; Cui T; Srivastava AK; Qu M; Yang L; Wei S; Zheng Y; Wang QE
    Tumour Biol; 2016 Oct; 37(10):14183-14191. PubMed ID: 27553023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
    Zhao W; Xie Y
    Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitization of esophageal carcinoma cells by knockdown of HMGB1 expression.
    Zhang X; Yang X; Zhu S; Li Q; Zou N
    Oncol Rep; 2019 Mar; 41(3):1960-1970. PubMed ID: 30569171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted inhibition of acidic nucleoplasmic DNA-binding protein 1 enhances radiosensitivity of non-small cell lung cancer.
    Gou W; Yu X; Wu S; Wu H; Chang H; Chen L; Wei H; Bi C; Ning H; Wu Y; Hou W; Zuo D; Li Y
    Cancer Lett; 2022 Apr; 530():100-109. PubMed ID: 35065237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing UCHL3 enhances radio-sensitivity of non-small cell lung cancer cells by inhibiting DNA repair.
    Liu M; Chen H; Chen X; Xiong J; Song Z
    Aging (Albany NY); 2021 May; 13(10):14277-14288. PubMed ID: 34016790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
    Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
    Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
    Luo F; Zhao Y; Liu J
    Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-219a-5p enhances the radiosensitivity of non-small cell lung cancer cells through targeting CD164.
    Wei T; Cheng S; Fu XN; Feng LJ
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32364222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab radiosensitizes non-small cell lung cancer xenografts by inhibiting DNA double-strand break repair in endothelial cells.
    Gao H; Xue J; Zhou L; Lan J; He J; Na F; Yang L; Deng L; Lu Y
    Cancer Lett; 2015 Aug; 365(1):79-88. PubMed ID: 25982206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site.
    Zhang Z; Huo H; Liao K; Wang Z; Gong Z; Li Y; Liu C; Hu G
    Exp Cell Res; 2018 Oct; 371(2):330-341. PubMed ID: 30144445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer.
    Zhang J; Sun B; Ruan X; Hou X; Zhi J; Meng X; Zheng X; Gao M
    Cancer Biol Med; 2021 Feb; 18(1):105-119. PubMed ID: 33628588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p53-53BP1-Related Survival of A549 and H1299 Human Lung Cancer Cells after Multifractionated Radiotherapy Demonstrated Different Response to Additional Acute X-ray Exposure.
    Pustovalova M; Alhaddad L; Smetanina N; Chigasova A; Blokhina T; Chuprov-Netochin R; Osipov AN; Leonov S
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-30a radiosensitizes non-small cell lung cancer by targeting ATF1 that is involved in the phosphorylation of ATM.
    Guo Y; Sun W; Gong T; Chai Y; Wang J; Hui B; Li Y; Song L; Gao Y
    Oncol Rep; 2017 Apr; 37(4):1980-1988. PubMed ID: 28259977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown GTSE1 enhances radiosensitivity in non-small-cell lung cancer through DNA damage repair pathway.
    Lei X; Du L; Zhang P; Ma N; Liang Y; Han Y; Qu B
    J Cell Mol Med; 2020 May; 24(9):5162-5167. PubMed ID: 32202046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHAF1B promotes proliferation and reduces apoptosis in 95‑D lung cancer cells and predicts a poor prognosis in non‑small cell lung cancer.
    Duan Y; Liu T; Li S; Huang M; Li X; Zhao H; Li J
    Oncol Rep; 2019 Apr; 41(4):2518-2528. PubMed ID: 30720130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression.
    Wan L; Sun M; Liu GJ; Wei CC; Zhang EB; Kong R; Xu TP; Huang MD; Wang ZX
    Mol Cancer Ther; 2016 May; 15(5):1082-94. PubMed ID: 26908628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.